EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements

Valéria Tavares iD, Inês Soares Marques, Inês Guerra de Melo, Joana Assis, Deolinda Pereira, Rui Medeiros iD

International Journal of Molecular Sciences · 03.02.2024 · 25 (3) · 1845

DOI: 10.3390/ijms25031845 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2024. Verfasst von Valéria Tavares und 5 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP), Pathology and Laboratory Medicine Department, Clinical Patholog…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Genital Neoplasms, Female. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 270 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para Ciência e Tecnologia (FCT), FCT, co-financed by the European Social Funds (FSE) and national funds of MCTES, FCT/MCTES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) is the female genital malignancy with the highest lethality. Patients present a poor prognosis mainly due to the late clinical presentation allied with the common acquisition of chemoresistance and a high rate of tumour recurrence. Effective screening, accurate diagnosis, and personalised multidisciplinary treatments are crucial for improving patients’ survival and quality of life. This comprehensive narrative review aims to describe the current knowledge on the aetiology, prevention, diagnosis, and treatment of OC, highlighting the latest significant advancements and future directions. Traditionally, OC treatment involves the combination of cytoreductive surgery and platinum-based chemotherapy. Although more therapeutical approaches have been developed, the lack of established predictive biomarkers to guide disease management has led to only marginal improvements in progression-free survival (PFS) while patients face an increasing level of toxicity. Fortunately, because of a better overall understanding of ovarian tumourigenesis and advancements in the disease’s (epi)genetic and molecular profiling, a paradigm shift has emerged with the identification of new disease biomarkers and the proposal of targeted therapeutic approaches to postpone disease recurrence and decrease side effects, while increasing patients’ survival. Despite this progress, several challenges in disease management, including disease heterogeneity and drug resistance, still need to be overcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsGenital Neoplasms, FemaleHumansFemaleQuality of LifeNeoplasm Recurrence, LocalBiomarkers

Stichwörter der Autor:innen

antineoplastic protocolsbiomarkersdiagnosisearly detection of cancerovarian neoplasms

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP), Pathology and Laboratory Medicine Department, Clinical Pathology SV/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Insti…
  • Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal.
  • ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, 4050-313 Porto, Portugal.
  • Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.
  • Clinical Research Unit, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto,…
  • Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072 Porto, Portugal.

ORCID-Profile: Valéria Tavares, Rui Medeiros

Förderung

  • Fundação para Ciência e Tecnologia (FCT)
  • FCT, co-financed by the European Social Funds (FSE) and national funds of MCTES
  • FCT/MCTES

Zitieren

APA

Tavares, V., Marques, I. S., Melo, I. G., Assis, J., Pereira, D., & Medeiros, R. (2024). Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements. International Journal of Molecular Sciences, 25(3), 1845. https://doi.org/10.3390/ijms25031845

Vancouver

Tavares V, Marques IS, Melo IG, Assis J, Pereira D, Medeiros R. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements. International Journal of Molecular Sciences. 2024;25(3):1845. doi:10.3390/ijms25031845

BibTeX
@article{Tavares2024,
  author = {Tavares, Valéria and Marques, Inês Soares and Melo, Inês Guerra de and Assis, Joana and Pereira, Deolinda and Medeiros, Rui},
  title = {Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1845},
  doi = {10.3390/ijms25031845}
}
Kostenlos starten →